Drug Information

Drug General Information
Drug ID
D0GW6K
Former ID
DNCL003084
Drug Name
ADX N05
Indication Mood disorder [ICD10:F30-F39] Phase 3 [548910]
Excessive daytime sleepiness [ICD9: 291.82, 292.85, 307.43-307.44, 327.1, 780.53-780.54; ICD10:F51.1, G47.1] Phase 2 [548910]
Company
Aerial BioPharma
Target and Pathway
Target(s) Sigma(1)-type opioid receptor Target Info Modulator [551695]
WikiPathways miR-targeted genes in squamous cell - TarBase
miR-targeted genes in lymphocytes - TarBase
References
Ref 548910Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030225)
Ref 551695Clinical pipeline report, company report or official report of SK BioPhamaceuticals.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.